2025-07-17T08:28:35-05:00 2024-12-31 382706146 YEO & YEO PC 1450 Eisenhower Place Ann Arbor MI 481083283 990 2024-01-01 382117115 Eversight EVER 8002477250 3985 Research Park Drive Ann Arbor MI 48108 Brian Roberts Chief Financial Officer 8002477250 2025-05-20 1 1 Brian R Dixon P01321580 7347691331 2025-07-16 2024 2025-03-06 01:10:19Z Brian Roberts 3985 Research Park Drive Ann Arbor MI 48108 48995418 0 X www.eversightvision.org X 1986 MI Eversight is a 501(c)3 nonprofit organization with the mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. The Eversight network is responsible for recovering, evaluating and providing human eye tissue for transplantation; advancing research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. Founded in 1947, Eversight maintains its commitment to excellence as an accredited member of the Eye Bank Association of America (EBAA) and by meeting the highest quality standards set by the U.S. Food and Drug Administration. The nonprofit operates 24/7/365 in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea, and collaborates with surgeons, researchers, academic medical centers and eye banks across the United States and abroad. Eversight works with the 15 15 187 64 0 0 1283375 1166781 27810618 30572532 1529170 2281435 39192 19128 30662355 34039876 0 60000 0 0 13586009 14610374 0 0 642188 13940924 15933621 27526933 30603995 3135422 3435881 45849022 48487446 23048867 22914001 22800155 25573445 X Eversight's mission is to restore sight and prevent blindness through the healing power of donation, transplantation and research. Blinding eye diseases affect 80 million Americans. That means millions of people cannot see their loved ones, drive to work or read the newspaper on a Sunday morning. Their vision loss results in an economic impact of $51.4 billion every year in the United States alone. Eversight envisions a world without blindness-a world where all mothers can see their children and all children can grow up to lead independent, productive lives through the gift of sight. To make vision a reality for all, Eversight continuously works to expand its reach, connect more effectively with communities in need and provide the gift of sight to everyone. 0 0 23033157 28388552 RESORING SIGHT Eversight continues to take meaningful steps toward transforming the future of vision care by supporting sustainable eye banking infrastructure and providing priceless clinical education. In 2024, Eversight provided the gift of sight to more than 10,200 people across the United States and around the world. Eversight provided 59 corneas for sight-restoring transplants gratis or at a reduced fee for uninsured patients.Eversight's work began in 1947 with the establishment of the fourth eye bank in the United States, then known as the Illinois Eye-Bank. Over time, nonprofit eye banks were established in every state to meet the critical demand for corneal tissue to treat preventable blindness.In 1985, the Illinois Eye-Bank and Michigan Eye-Bank formed a partnershipone that would earn a reputation for clinical excellence made possible by some of the finest medical directors, staff and board members in the eye banking field. The success of the organization attracted affiliations with other regional eye banks forming one of the largest networks of eye banks in the U.S. In 2015, the network became known as Eversight, all working together as a unified operation to deliver the highest quality services to surgeons and their patients and to continue to grow our impact around the world.Eversight provided more than 14,900 tissues for transplantation, research and education globally in 2024. We worked or placed tissue with physicians and researchers in 34 countries and facilitated training for 918 clinicians. Together with all our partnersadvocates, donor families, transplant recipients, surgeons, Lions, fellow eye banks, healthcare leaders, philanthropic supporters and many otherswe were able to make vision a reality for more people worldwide. 193609 60000 75664 FINDING A CURE In the pursuit of eliminating blinding eye diseases, Eversight established the Eversight Center for Vision and Eye Banking Research in Cleveland, Ohio, to provide leading ophthalmology researchers with the resources they need to find cures and treatments for eye diseases such as age-related macular degeneration, diabetic retinopathy and glaucoma. Eversight provided more than 4,700 tissues for research and education purposes in 2024. Our in-house research team also provided Eversight partners with valuable research and development services and pioneered new eye banking practices.Since 2014, the Eversight researchers have authored 50 publications and given 34+ presentations at international conferences. The team published six publications in 2024 on: comparing cornea storage medias, perceptions of cornea and eye donation, automated counting and density of donor endothelial cells, protocol for corneal stromal stem cell cultivation, using trypan blue for cell viability after preloading DMEK grafts, and docosahexaenoic acid in diabetic humans and mice. With our many academic partners, Eversight researchers have contributed to over 250 peer-reviewed scientific papers that have garnered 6,300 citations and counting.Eversight has a longstanding track record of research and development, having awarded more than $4 million in grants to date that stimulate pioneering clinical and basic science research aiming to develop new ways to restore sight, prevent blindness and ultimately help patients live life to the fullest. Since 1980, our Eye & Vision Research Grant Program has supported researchers at leading academic medical institutions including Harvard, Tufts, Cleveland Clinic, Case Western Reserve, University of Michigan, Northwestern and more. By design, Eversight's grant program provides critical, early-stage funding that is intended to drive foundational research and discovery. Many of these projects have stimulated larger-scale studies and won further financial support from the National Institutes of Health.In the 2025 funding cycle, Eversight awarded four grants at Loyola University Chicago, University of Houston, University of Illinois Chicago and University of Michigan to advance studies to investigate developing a novel drug evaluation system to stimulate blood vessel growth experimentally using factors that have been linked to the pathophysiology of both wAMD and PDR; enhancing limbal stem cell preservation; understanding the biomechanics of keratoconus by looking at the composition and microstructure of normal human and keratoconus corneal extracellular matrix; and advancing therapies for ocular surface squamous neoplasia. Each year, recipients are selected by an independent review panel of academic researchers and ophthalmologists. This distinguished panel awards proposals that encourage meaningful scientific inquisition and align with Eversight's mission to restore sight and prevent blindness through the healing power of donation, transplantation and research. 1062560 2108316 SUSTAINABLE INTERNATIONAL IMPACTEversight works to eliminate corneal blindness worldwide through eye bank development, clinical training and tissue provision. With more than 75 years of eye banking expertise, we deliver both short- and long-term solutions to transform the lives of more than 12 million people suffering from corneal blindness globally. In 2024, Eversight International provided more than 4,200 tissues for transplant and worked with surgeons in 33 countries outside the United States, making the gift of sight possible for many in need. Eversight provided 76 cornea tissues for sight-restoring transplants gratis or at a reduced rate for medical missions and uninsured patients outside the United States.In medically underserved areas, Eversight Global Development fosters authentic relationships with local leaders to establish culturally informed eye donation frameworks and sustainable eye banking infrastructure. Our experienced team offers vital clinical training and education to eye surgeons and eye bank technicians on the latest clinical methods, improving access to life-changing transplants. Through the incredible generosity of our donors and donor families, Eversight Global Development also provides corneal tissue from the United States for transplant and research globally, providing hope for the future and restoring sight to patients in need. Our global mission is informed by and aligns with the United Nations Sustainable Development Goals (SDGs), with particular attention given to: #3 Good Health and Well-being, #4 Quality Education, #8 Decent Work and Economic Growth, #10 Reduced Inequalities and #11 Sustainable Cities & Communities. According to the World Health Organization, every dollar spent on improving eye health in underdeveloped areas generates a four-fold return on investment. To address systemic unmet need, Eversight actively works with medical professionals, governments, vision health organizations and other NGOs in regions lacking eye banks and infrastructure, including United Arab Emirates, Pakistan and South Korea. With proven eye banking and technical training practicesand having played a part in the elimination of the U.S. cornea transplant waiting listEversight is uniquely qualified to work with countries lacking transplant programs to help them establish national networks for eye banking and cornea donation with culturally appropriate donation models and state-of-the-art clinical capabilities.Globally, an estimated 2.2 billion people are impacted by blindness and visual impairment. Ninety percent of vision-impaired people live in low- and middle- income countries. Approximately one billion of these individuals are coping with blindness or visual impairment that can be characterized as preventable or not sufficiently addressed. Vision loss results in substantial economic impact worldwide due to the inability of people who are vision impaired to contribute to their fullest in their communities. Eversight envisions a world without blindnessa world where all people in every community can lead independent, productive lives through the gift of sight. While providing for immediate global cornea transplant needs with U.S. donor tissue, Eversight continues to address the global burden by empowering international communities to take meaningful, sustainable steps every day to make vision a reality for all. 24289326 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 0 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 25 0 1 187 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 15 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MI IL X Brian Roberts 7347802119 3985 Research Park Drive Ann Arbor MI 48108 Patty Jo Herndon Imm. Past Chair 1.00 X X 0 0 0 Kathy L Zelenock Chair 1.00 X X 0 0 0 Joseph M Maiuri Treasurer 1.00 X X 0 0 0 Mahmoud N Ghazzi MD PhD Secretary 1.00 X X 0 0 0 Lorenzo Cervantes MD Director 1.00 X 0 0 0 Jonathan Lass MD Director 1.00 X 0 0 0 Shahzad Mian MD Director 1.00 X 0 0 0 Carol Cunningham MD Director 1.00 X 0 0 0 Probi Kapur Director 1.00 X 0 0 0 Carolyn M Welsh Vice-Chair 1.00 X 0 0 0 Sandra Fletcher Director 1.00 X 0 0 0 Peter Wroblewski Director 1.00 X 0 0 0 Jill Maher MA COE Director 1.00 X 0 0 0 John Ryan Director 1.00 X 0 0 0 Diane Hollingsworth President & CEO 50.00 X 302974 0 34437 Michael O'Keefe Chief Operations Officer 50.00 X 209314 0 29609 Julie Collins Chief Finance & Administrative Officer 50.00 8.00 X 215850 0 29609 Michael Titus Sr. VP, Clinical Services 50.00 X 218538 0 34243 Bret Hopman SR. VP, Marketing & Communications 50.00 X 165861 0 32569 Onkar Sawant VP, Research & Innovations 50.00 X 168441 0 13111 Caitlin Lopes Partner Relations Director 50.00 X 126027 0 33249 Catherine McClory Director, Compliance & Quality Assurance 50.00 X 157251 0 12724 Indu Vadakkepattath Data Scientist/Applications Manager 50.00 X 150320 0 12134 Joseph Zullo Manager, Information Technology 50.00 X 114985 0 16481 Kara Kelley Partner Relations Director 50.00 X 109886 0 9468 1939447 0 257634 16 0 1 0 Dunham Square Land LLC 10020 Aurora Hudson Road Streetsboro OH 44241 Facilities maintenance and repair 248159 Data Intuitions 50718 Siverton Canton MI 48187 Software consultant 234243 Mural Park LLC (Frontline) 477 Elm Place Highland Park IL 60035 Office and lab rent 196407 Toranco-Clark Associates LLC 2163 Oak Tree Road Suite 101 Edison NJ 08820 Office and lab rent 104851 4 29670 1137111 14201 1166781 Eye Tissue Fees 621500 28388552 28388552 Intercompany charges 621500 2108316 2108316 Other revenue 621500 75664 75664 30572532 619672 619672 16587646 14925883 1661763 1661763 1661763 48787 29670 29659 19128 19128 34039876 30572532 0 2300563 60000 60000 1454566 420475 1034091 9596333 7622506 1599142 374685 446691 364419 64080 18192 2205850 1671469 455223 79158 906934 667049 208644 31241 16537 7169 9368 120152 52089 68063 380305 164871 215434 27620 27620 45361 16424 27619 1318 250676 122107 121968 6601 1517845 738159 738753 40933 177244 74576 100330 2338 296301 54839 233701 7761 252773 122928 123028 6817 436104 213343 212432 10329 Clinical Lab & Tech Exp 11536032 11536032 Miscellaneous 279921 1799 277569 553 Business Development 178203 70192 105026 2985 Membership Dues 167001 167001 251546 141879 50390 59277 30603995 24289326 5672481 642188 3479320 4017484 4246975 4544869 3851794 3714765 1000000 148372 210148 13951451 7807581 8610135 6143870 12720929 14042529 -1338359 14129856 14813781 45849022 48487446 2109308 1808284 400 400 6510250 14428909 21105317 23048867 22914001 X 22568195 25444203 231960 129242 22800155 25573445 45849022 48487446 3435881 -639148 -23443 0 X X 0 1 X 1 0 X 672370 3627186 864304 1283375 1166781 7614016 19849742 23990620 24444041 27810618 30572532 126667553 20522112 27617806 25308345 29093993 31739313 134281569 3750 400130 403880 8766065 3989386 6290645 6665837 7720603 33432536 8769815 4389516 6290645 6665837 7720603 33836416 100445153 142247 156491 181255 643775 619672 1743440 142247 156491 181255 643775 619672 1743440 20345 659 43903 38192 48787 151886 20684704 27774956 25533503 29775960 32407772 136176895 0.73760 0.78190 0.01280 0.01080 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 179087 179087 179087 179087 179087 179087 179087 179087 179087 179087 0.49000 0.51000 0 0 1288299 817771 470528 1696029 1316722 379307 10967123 5673088 5294035 6143870 Receivable from related entity 14716713 Deposit 97068 14813781 Payable to related entity 14904050 Operating lease obligation 293247 Finance lease obligation 5908020 21105317 33406944 -639148 -639148 34046092 23443 -29659 -6216 34039876 30633654 29659 29659 30603995 0 30603995 Part V, Line 4: The purpose of the Gift of Hope Eye and Vision Research Endowment Fund is to provide for annual distributions to support Eversight's Gift of Hope Eye and Visions Research Program. The purpose of the Gift of Sight Charitable Endowment Fund is to provide for annual distributions to support Eversight's program which waives tissue processing fees, or reduces the fee for patients who are unable to pay the full amount. The purpose of the Community Education Endowment Fund is to provide for annual distributions to support Eversight's Community Education Program. Part XI, Line 4b - Other Adjustments: Special event expenses Part XII, Line 2d - Other Adjustments: Special event expenses Night for Sight 48019 14766 33253 16569 952 6848 Golf for Good! 30438 14904 15534 1326 3964 78457 29670 48787 17895 952 10812 29659 19128 0 Scholarships 4 60000 Cash Scholarships X X X 0 0 0 0 0 0 0 0 0 Diane Hollingsworth President & CEO 302974 0 0 0 0 0 18128 0 16309 0 337411 0 0 0 Michael Titus Sr. VP, Clinical Services 218538 0 0 0 0 0 13831 0 20412 0 252781 0 0 0 Julie Collins Chief Finance & Administrative Offic 215850 0 0 0 0 0 13300 0 16309 0 245459 0 0 0 Michael O'Keefe Chief Operations Officer 209314 0 0 0 0 0 13300 0 16309 0 238923 0 0 0 Bret Hopman SR. VP, Marketing & Communications 165861 0 0 0 0 0 12157 0 20412 0 198430 0 0 0 Onkar Sawant VP, Research & Innovations 168441 0 0 0 0 0 10711 0 2400 0 181552 0 0 0 Catherine McClory Director, Compliance & Quality Assur 157251 0 0 0 0 0 10324 0 2400 0 169975 0 0 0 Indu Vadakkepattath Data Scientist/Applications Manager 150320 0 0 0 0 0 9734 0 2400 0 162454 0 0 0 Caitlin Lopes Partner Relations Director 126027 0 0 0 0 0 8983 0 24266 0 159276 0 0 0 Form 990, Part VI, Section B, line 11b The 990 is reviewed by the CEO and CFO prior to filing. Completed 990 is provided via e-mail to all Board members for comments and questions prior to filing. Form 990, Part VI, Section B, line 12c The policy is reviewed during new employee orientation and annually withthe entire staff and Board of Directors. Any potential conflicts ofinterest are reviewed by Senior Staff upon discovery. Form 990, Part VI, Section B, line 15 A performance review is conducted by the Board HR Committee with CEO; meritincrease is recommended by the HR committee and approved by the Board. TheCEO is not part of compensation discussion and CEO does not participate inthe selection of Board members. The CEO salary is compared to salaries ofother CEO's at peer organizations; other eye banks, OPOs, other nonprofitorganizations of similar size. In 2016 the organization engaged theservices of an independent consultant to conduct a Leadership Compensationanalysis. Their source of salary information is the 990's issued by peerorganizations, Michigan Nonprofit Association Salary Survey, publishedbudgets, web-based research through FOIA sources and independent salarysurvey data.Performance review for officers and key employees is conducted by theemployees' immediate manager; merit increases are recommended by themanager and approved by the CEO. Salaries of officers and key employees arecompared to salaries of other similar positions at peer organizations;other eye banks, OPOs, other nonprofit organizations of similar size. Areport is provided to the HR committee of the Board of Directors for theirreview. In 2016 the organization engaged the services of an independentconsultant to conduct a Leadership Compensation analysis. Their source ofsalary information is the 990's issued by peer organizations, MichiganNonprofit Association Salary Survey, published budgets, web-based researchthrough FOIA sources and independent salary survey data. Form 990, Part VI, Section C, line 19 Governing documents are available upon request. Form 990, Part XII, Line 2c: No changes from prior years. Eversight International 3985 Research Park Drive Ann Arbor MI 48108 471671769 Eye Bank MI 501(c)(3) Line 10 Eversight 1 Eversight New Jersey 77 Brant Ave Suite 100 Clark NJ 07066 203345087 Eye Bank NJ 501(c)(3) Line 7 Eversight 1 Eversight Michigan 3985 Research Park Drive Ann Arbor MI 48108 273107692 Eye Bank MI 501(c)(3) Line 7 Eversight 1 Eversight Illinois 547 West Jackson Blvd Suite 600 Chicago IL 60661 273107617 Eye Bank IL 501(c)(3) Line 7 Eversight 1 Midwire Systems 3985 Research Park Drive Ann Arbor MI 48108 383557111 Software MI 501(c)(3) Line 10 Eversight 1 Eversight Ohio 6700 Euclid Ave Suite 101 Cleveland OH 44103 455111431 Eye Bank OH 501(c)(3) Line 7 Eversight 1 Eversight Connecticut 3985 Research Park Drive Ann Arbor MI 48108 475113503 Eye Bank CT 501(c)(3) Line 7 Eversight 1 Eversight Korea LLC 145 A 1638 Tehran-ro Gumcheongu Seoul KS Eye Bank KS Ever Int C 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 Eversight International L 1548920 Cost Eversight International O 559396 Cost